Longitudinal follow-up and prognostic factors in nitrous oxide-induced neuropathy.
N2O
follow‐up
longitudinal
neuropathy
nitrous oxide
toxic
Journal
Journal of the peripheral nervous system : JPNS
ISSN: 1529-8027
Titre abrégé: J Peripher Nerv Syst
Pays: United States
ID NLM: 9704532
Informations de publication
Date de publication:
21 May 2024
21 May 2024
Historique:
revised:
10
05
2024
received:
26
03
2024
accepted:
11
05
2024
medline:
22
5
2024
pubmed:
22
5
2024
entrez:
21
5
2024
Statut:
aheadofprint
Résumé
Recreational use of nitrous oxide (N We gathered demographic, clinical, biological, and electrophysiological data from N We retrospectively included 26 N The clinical course generally improved favorably at 6 months with notable amelioration in the primary disability scores, sensory deficits, and ataxia. However, distal motor impairment associated with peripheral neuropathy persisted, with distal axonal loss emerging as the main prognostic factor for long-term disability in these young patients.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
Recreational use of nitrous oxide (N
METHODS
METHODS
We gathered demographic, clinical, biological, and electrophysiological data from N
RESULTS
RESULTS
We retrospectively included 26 N
INTERPRETATION
CONCLUSIONS
The clinical course generally improved favorably at 6 months with notable amelioration in the primary disability scores, sensory deficits, and ataxia. However, distal motor impairment associated with peripheral neuropathy persisted, with distal axonal loss emerging as the main prognostic factor for long-term disability in these young patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Peripheral Nerve Society.
Références
van Amsterdam J, Nabben T, van den Brink W. Recreational nitrous oxide use: prevalence and risks. Regul Toxicol Pharmacol. 2015;73(3):790‐796.
French Association of Addictovigilance Centres, Micallef J, Mallaret M, et al. Warning on increased serious health complications related to non‐medical use of nitrous oxide. Therapie. 2021;76(5):478‐479. doi:10.1016/j.therap.2020.01.002
Ehirim EM, Naughton DP, Petróczi A. No laughing matter: presence, consumption trends, drug awareness, and perceptions of “hippy crack” (nitrous oxide) among young adults in England. Front Psych. 2017;8:312.
Massey TH, Pickersgill TT, Peall KJ. Nitrous oxide misuse and vitamin B12 deficiency. Case Rep. 2016;2016:bcr2016215728.
Layzer RB, Fishman RA, Schafer JA. Neuropathy following abuse of nitrous oxide. Neurology. 1978;28(5):504‐506.
Mair D, Paris A, Zaloum SA, et al. Nitrous oxide‐induced myeloneuropathy: a case series. J Neurol Neurosurg Psychiatry. 2023;94(9):681‐688. doi:10.1136/jnnp‐2023‐331131
Swart G, Blair C, Lu Z, et al. Nitrous oxide‐induced myeloneuropathy. Eur J Neurol. 2021;28(12):3938‐3944.
Li Y, Zhang X, Zhao C. Electrophysiological characteristics of patients with nitrous oxide abuse. Neurol Res. 2021;43(10):793‐801.
Fang X, Yu M, Zheng D, Gao H, Li W, Ma Y. Electrophysiologic characteristics of nitrous‐oxide‐associated peripheral neuropathy: a retrospective study of 76 patients. J Clin Neurol. 2023;19(1):44‐51.
Fortanier E, Berling E, Zanin A, et al. How to distinguish Guillain‐Barré syndrome from nitrous oxide‐induced neuropathy: a 2‐year, multicentric, retrospective study. Eur J Neurol. 2023;30(10):3296‐3306. doi:10.1111/ene.15998
Qin X, Kang L, Liu X, et al. Acute nitrous oxide‐induced neuropathy mimicking Guillain‐Barré syndrome. J Peripher Nerv Syst. 2022;27(3):189‐196.
Jiang J, Shang X, Wang X, et al. Nitrous oxide‐related neurological disorders: clinical, laboratory, neuroimaging, and electrophysiological findings. Brain Behav. 2021;11(12):e2402.
Einsiedler M, Voulleminot P, Demuth S, et al. A rise in cases of nitrous oxide abuse: neurological complications and biological findings. J Neurol. 2022;269(2):577‐582.
Grzych G, Deheul S, Gernez E, et al. Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective study. J Neurol. 2023;270(4):2237‐2245.
Gernez E, Deheul S, Tard C, Joncquel M, Douillard C, Grzych G. Plasma methionine and clinical severity in nitrous oxide consumption. Toxics. 2022;11(1):12. doi:10.3390/toxics11010012
Berling E, Fargeot G, Aure K, et al. Nitrous oxide‐induced predominantly motor neuropathies: a follow‐up study. J Neurol. 2022;269(5):2720‐2726.
Zheng R, Wang Q, Li M, et al. Reversible neuropsychiatric disturbances caused by nitrous oxide toxicity: clinical, imaging and electrophysiological profiles of 21 patients with 6‐12 months follow‐up. Neuropsychiatr Dis Treat. 2020;16:2817‐2825. doi:10.2147/NDT.S270179
Burke D. Clinical uses of H reflexes of upper and lower limb muscles. Clin Neurophysiol Pract. 2016;1:9‐17. doi:10.1016/j.cnp.2016.02.003
Fortanier E, Delmont E, Verschueren A, Attarian S. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol. 2020;131(5):1129‐1133. doi:10.1016/j.clinph.2020.01.022
Allan J, Cameron J, Bruno J. A systematic review of recreational nitrous oxide use: implications for policy, service delivery and individuals. Int J Environ Res Public Health. 2022;19(18):11567.
Paris A, Lake L, Joseph A, et al. Nitrous oxide‐induced subacute combined degeneration of the cord: diagnosis and treatment. Pract Neurol. 2023;23(3):222‐228. doi:10.1136/pn‐2022‐003631
Dawudi Y, Azoyan L, Broucker TDE, et al. Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the greater Paris area. J Neurol. 2024. doi:10.1007/s00415‐024‐12264‐w
Li HT, Chu CC, Chang KH, et al. Clinical and electrodiagnostic characteristics of nitrous oxide‐induced neuropathy in Taiwan. Clin Neurophysiol. 2016;127(10):3288‐3293.
Zoccolella S, Simone IL, Lamberti P, et al. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis. Neurology. 2008;70(3):222‐225. doi:10.1212/01.wnl.0000297193.53986.6f
Stewart KJ, Iskandar BJ, Meier BM, et al. Nitrous oxide impairs axon regeneration after nervous system injury in male rats. Anesthesiology. 2019;131(5):1063‐1076. doi:10.1097/ALN.0000000000002906
Ruijter BJ, de Mooij MJ, Bruijnes JE, van Oosterhout WPJ, Kwa VIH. Neurological complications of excessive recreational nitrous oxide use: a case series based on a text mining algorithm. J Neurol. 2023;271:1267‐1276. doi:10.1007/s00415‐023‐12061‐x
Green R, Allen LH, Bjørke‐Monsen AL, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040. doi:10.1038/nrdp.2017.40 Erratum in: Nat Rev Dis Primers 2017 Jul 20;3:17054. PMID: 2866089.